Cope, ABC, La Rioja, among other media, have published an article about the inscriptions to the IV Women's Race for Research from Asociación Española Contra el Cáncer (AECC). The resources obtained from this race will be used to finance two predoctoral grants at two institutions in La Rioja. Also, the project "Research on the impact of senescence influenced by inflammation as a therapy on cancer stem cells" led by Marta Kovatcheva, researcher at IRB Barcelona, will be financed.
Link to Cope...
La Razón and Info Diabético have each published an article about the work done by Manuel Serrano at IRB Barcelona: "If we eliminate damaged cells, the function of aged tissues is greatly improved, that is, they are rejuvenated," says Serrano, who goes on to point out that "it has been possible to delay and reverse the aging of small mammals, such as mice, with the use of experimental drugs that eliminate damaged cells."
Link to La Razón
“Futuro a fondo” has published an article about the video "Meet Our Scientists", starring Manuel Serrano, a researcher at IRB Barcelona. In the video he talks about his research into how damaged tissues are repaired and therapies based on regenerative medicine.
Link to Futuro a fondo
The projects address breast, lung, colon, prostate and melanoma cancer.
Manuel Serrano, ICREA researcher at IRB Barcelona, is the subject of the next video in the Meet Our Scientists series: “Killing zombie cells”.
In the video, Serrano talks about the work undertaken in his lab to find compounds that can remove damaged cells from the body.
TV3's "Telenotícies" programme interviewed Miguel Rovira, a PhD student at IRB Barcelona and the first author of a recent study published in the journal EMBO Molecular Medicine. In this study, the scientists designed a nano-carrier to release drugs into damaged cells.
Link to TV3
Link to TV3 (vídeo)
El Punt Avui, Al Día, Noticias de la Ciencia, Catalunya Press, among other media, have published an article about a study led by Manuel Serrano, leader of the Laboratory of Cellular Plasticity and Disease at IRB Barcelona, which establishes therapeutic opportunities to eliminate senescent cells in diseases such as cancer.
Link to El Punt Avui
Link to Al Día
A team headed by Manuel Serrano at IRB Barcelona has designed a drug encapsulation system that selectively targets senescent cells.
The study paves the way for therapeutic approaches to eliminate senescent cells in many diseases, such as pulmonary fibrosis and cancer.
BIST Director General says modernising research facilities and providing training to boost the social impact of science are the top priorities of the Barcelona Institute of Science and Technology
Barry C. Barish presents theory and technology behind measuring gravitational waves developed at LIGO, for which he won the 2017 Nobel Prize in Physics
TV3’s "30 Minuts" has devoted a programme to whether it will be possible to extend life beyond the current limits, by slowing down or stopping aging as if it were a disease. For this documentary, they interviewed Manuel Serrano, ICREA researcher at IRB Barcelona, who comments on the process of senescence and zombie cells: "For example, if you smoke, the aging process accelerates and these zombie cells accumulate".
Link to TV3